Macquarie Group’s Neos Therapeutics, Inc NEOS Stock Holding History

Macquarie Group’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,500	Closed	-$36K	–	2471
2017 Q4	$36K	Buy	+3,500	New	+$33.6K	﹤0.01%	2043

Other funds holding NEOS

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSC

Lyon Street Capital Sausalito, California $67M AUM

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group's NEOS Position: Q1 2018 in Review

Macquarie Group sold out of Neos Therapeutics, Inc (NEOS) in Q1 2018, closing a stake of 3,500 shares — an estimated $36K sold.

Macquarie Group first reported a position in NEOS in Q4 2017 and held it in 1 quarter. The position peaked at $36K in Q4 2017. 77 funds tracked by Wall St. Rank hold NEOS as of Q1 2018.

Macquarie Group reported no remaining Neos Therapeutics, Inc position as of Q1 2018 after selling out during the quarter.
Macquarie Group sold 3,500 Neos Therapeutics, Inc shares in Q1 2018, an estimated $36K.
Macquarie Group first reported a position in Neos Therapeutics, Inc in Q4 2017 and held it in 1 quarter.
Macquarie Group's Neos Therapeutics, Inc position peaked at $36K in Q4 2017.
77 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.